Recombinant Saccharomyces cerevisiae HYP2 Protein ，His & SUMO

HYP2, or Hypoxia-Inducible Factor 2 Alpha (HIF-2α), plays a crucial role in cellular responses to hypoxic conditions, regulating genes involved in angiogenesis, erythropoiesis, and metabolism. Researchers have become increasingly interested in HYP2 due to its implications in various pathological conditions, including cancer, where its overexpression may contribute to tumor progression and metastasis, as well as in ischemic diseases, where it aids in tissue adaptation by promoting blood vessel formation. The ability of HYP2 to modulate cellular responses to oxygen availability highlights its importance in maintaining homeostasis under stress conditions. Moreover, understanding the regulatory mechanisms of HYP2 not only paves the way for developing therapeutic strategies targeting its activity but also provides insights into the fundamental processes of cellular signaling and adaptation. Recombination technology has enabled the production of HYP2 recombinant proteins, facilitating detailed studies of its functional roles, interactions with other signaling pathways, and potential as a therapeutic target. Thus, research on HYP2 encompasses a multidisciplinary approach involving molecular biology, biochemistry, and clinical applications, underscoring its significance in both health and disease contexts.